Maxeran
Maxeran
- In many community pharmacies and from some online vendors it can sometimes be obtained without a prescription, but in most regulated markets (including Canada, the USA, UK, EU and Australia) metoclopramide (sold under names such as Maxeran/Maxolon/Reglan) is prescription‑only — availability varies by country and pharmacy.
- Maxeran (metoclopramide) is used to treat nausea and vomiting, migraine-related nausea, and to improve gastric emptying in gastroparesis and reflux; it works primarily as a dopamine (D2) receptor antagonist with prokinetic effects on the gastrointestinal tract and central antiemetic action.
- Usual adult dose: 10 mg up to three times daily (maximum 30 mg/day); paediatric dosing typically 0.1–0.15 mg/kg per dose, not to exceed 0.5 mg/kg/day; elderly and patients with significant renal impairment require lower or less frequent dosing.
- Available as oral tablets (including orally disintegrating tablets), oral solution/syrup, and injectable forms for IM/IV administration.
- Onset of effect: oral doses usually start to work within about 15–60 minutes; IM/IV dosing produces a faster effect (minutes).
- Duration of action: effects generally last around 4–6 hours after a single dose.
- Avoid alcohol while taking Maxeran — alcohol can increase drowsiness and other central nervous system side effects and may worsen adverse reactions.
- The most common side effect is drowsiness; other frequent effects include diarrhoea, restlessness/agitation and extrapyramidal symptoms (acute dystonia, tremor); long‑term use risks hyperprolactinaemia and tardive dyskinesia.
- Would you like to try maxeran without a prescription?
Basic Maxeran Information
- INN (International Nonproprietary Name): Metoclopramide
- Brand Names Available In Canada (English): not specified
- ATC Code: A03FA01
- Forms & Dosages: Tablets 10 mg (blister 10, 20, 30); Oral solution 5 mg/5 mL (100 mL); Injection 5 mg/mL (2 mL or 10 mL ampoules/vials)
- Manufacturers In Canada (English): not specified; world-based suppliers include Teva, Aurobindo, ANI Pharmaceuticals, Aspen, Accord, Mylan
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Prescription Only (Rx)
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Supply and pricing for metoclopramide — often searched for as Maxeran, Maxolon or Reglan — are fragmented across provinces due to formularies, distributor contracts and chain stocking choices.
Large retailers such as Shoppers Drug Mart, Rexall and London Drugs commonly stock generic metoclopramide 10 mg tablets and may obtain oral solution or injectable forms for clinic or hospital orders.
Availability of specific brands and pack sizes varies by store and province; patients in smaller centres sometimes need inter-branch transfer or special-order timing.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Online pharmacies, both chain and independent, increasingly list metoclopramide for prescription dispensing with mandatory Rx verification at upload or on delivery.
Provincial rules can affect shipment: some provinces restrict delivery of certain formulations or require additional verification when provincial drug plans are billed.
Cross-border ordering from U.S. sites is practiced by some Canadians but watch DIN differences, prescription validity and import rules for personal-use shipments.
Price Ranges By Package Size (With Provincial Differences)
Retail price for metoclopramide 10 mg tablets in Canada commonly ranges from CAD 6 to CAD 30 for blister packs (10–30 tablets), depending on brand or generic, pharmacy mark-up and provincial dispensing fees.
Oral solution bottles (100 mL, 5 mg/5 mL) often cost more than tablets because of packaging and lower turnover.
Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare, RAMQ and Alberta Health may cover metoclopramide under defined indications or with prior-authority requirements; out-of-pocket payments occur when special authorization is needed.
Price Comparison (Sample Ranges by Package Size):
| Package | Typical Retail Range (CAD) | Notes By Province |
|---|---|---|
| 10 x 10 mg tablets | 6–12 | Often lowest-cost generic; dispensing fee varies by province |
| 20–30 x 10 mg tablets | 10–30 | Pack size and brand affect price; Quebec and Ontario rebates apply for eligible patients |
| 100 mL oral solution (5 mg/5 mL) | 15–45 | Higher price due to liquid formulation and lower supplier volumes |
| Injection ampoules (clinic supply) | clinic supply pricing — varies | Usually supplied to hospitals/clinics via wholesaler contracts |
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Patients post real-world experiences on forums like Reddit, provincial Facebook groups and HealthBoards, often comparing brands, prices and effects.
Community threads show many users praise rapid relief from nausea and the usefulness of metoclopramide for migraine-associated nausea and post-operative vomiting.
Reported Benefits And Challenges From Canadian Patients
Pros reported by Canadian users include effective antiemesis at low cost and the convenience of short courses dispensed from local pharmacies.
Cons commonly mentioned include drowsiness, acute movement side effects and concerns about long-term use and tardive dyskinesia.
- Pros: fast relief for acute nausea, affordable generic options, helpful adjunct for migraines.
- Cons: risk of drowsiness, extrapyramidal symptoms, difficulty obtaining some formulations in rural areas.
Quote callout: “I took a single 10 mg tablet for my migraine nausea and felt better within an hour, but my aunt was warned about long-term use,” reports a patient in Ontario.
Many patients appreciate clear pharmacist counselling at Shoppers and Rexall, while others pay out-of-pocket if provincial coverage requires prior authorization.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
International Nonproprietary Name (INN) is metoclopramide.
Common international brands include Maxolon, Reglan and Metozolv ODT, but Canadian supply is primarily generic from multiple manufacturers and wholesalers; brand availability depends on supplier contracts.
Forms that appear in Canadian supply chains are 10 mg tablets, oral solution (5 mg/5 mL) and injectable 5 mg/mL ampoules for IM/IV use in clinics and hospitals.
Legal Classification Under Health Canada
Metoclopramide is prescription-only (Rx) in regulated markets and requires a valid prescription for dispensing in Canada.
Products marketed in Canada must display a Canadian Drug Identification Number (DIN) issued by Health Canada on the packaging and product monograph.
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Health Canada-associated product monographs and DIN listings typically recognise metoclopramide for symptomatic treatment of nausea and vomiting, facilitation of small-bowel intubation and short-term management of gastroparesis and gastrointestinal motility disorders.
Use for chemotherapy- or post-operative-related nausea is included in many monographs for short-term management.
Off-Label Patterns In Canadian Healthcare
Off-label uses in Canada include acute migraine-associated nausea as an adjunct to analgesics and limited paediatric use (1–18 years) when alternatives fail.
Provincial formularies often restrict reimbursement, for example requiring special-authority for chronic gastroparesis, and clinicians are advised to limit duration due to tardive dyskinesia risk.
| Use | Typical Status | Provincial Reimbursement Note |
|---|---|---|
| Acute Nausea/Vomiting | Approved short-term | Generally covered for acute indications with Rx |
| Gastroparesis | Short-term/specialist use | Often requires special-authority for chronic therapy |
| Migraine-Associated Nausea | Common adjunct (short course) | Usually out-of-pocket unless tied to other covered therapy |
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Metoclopramide helps reduce nausea and speeds stomach emptying by increasing muscle contractions in the gut and lowering signals that trigger vomiting in the brain.
It is often used when quick relief is needed or when improving stomach emptying will help other treatments work better.
Clinical Detail From Health Canada Resources
Pharmacologically, metoclopramide is a dopamine D2 receptor antagonist with some 5‑HT4 agonist activity that promotes gastric motility and blocks chemoreceptor trigger zones in the brainstem.
Health Canada product monographs note central nervous system penetration, which explains both therapeutic effects and the potential for extrapyramidal reactions.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Adults commonly receive 10 mg orally up to three times daily, with a maximum of 30 mg per day, for acute nausea and vomiting.
A single 10 mg dose is often used as an adjunct for migraine-related nausea.
Oral solution (5 mg/5 mL) permits weight-based dosing for children when specialist-prescribed.
Adjustments By Patient Type (With Canadian Clinical Notes)
Paediatric dosing is generally 0.1–0.15 mg/kg per dose with a maximum of 0.5 mg/kg/day for children 1–18 years, and specialists usually oversee such prescriptions.
Elderly patients require the lowest effective dose and close monitoring for extrapyramidal effects.
Renal impairment with GFR under 30 mL/min typically prompts halving the dose or lengthening the dosing interval, and hepatic impairment warrants caution and monitoring.
| Patient Group | Typical Dose | Administration Notes |
|---|---|---|
| Adults | 10 mg PO up to 3x/day | Max 30 mg/day; short courses preferred |
| Children (1–18 yrs) | 0.1–0.15 mg/kg/dose | Max 0.5 mg/kg/day; specialist supervision |
| Elderly | Lowest effective dose | Monitor closely for involuntary movements |
| Renal Impairment | Half dose or longer interval | Adjust if GFR <30 mL/min |
Contraindications & Side Effects
Common (Health Canada-Approved List)
Absolute contraindications include known hypersensitivity, gastrointestinal bleeding, obstruction or perforation, pheochromocytoma, epilepsy or seizure disorders, Parkinson’s disease and prolactin-dependent tumours.
Common side effects are drowsiness, fatigue, diarrhoea, headache, restlessness and acute extrapyramidal symptoms such as dystonia or tremor.
Rare But Serious (With Canadian Pharmacovigilance Data)
Long-term or cumulative exposure can lead to tardive dyskinesia, a potentially irreversible movement disorder reported in Canadian and international pharmacovigilance data.
Other rare serious events include neuroleptic malignant syndrome-like presentations and severe movement disorders; drug interactions with antipsychotics, serotonergic agents or CNS depressants increase risk.
- Common: drowsiness, diarrhoea, restlessness, mild movement symptoms.
- Serious (rare): tardive dyskinesia, severe dystonic reactions, neuroleptic malignant syndrome-like events.
Patients should be counselled to report involuntary movements immediately and to stop therapy if such symptoms appear.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
Before prescribing or switching, pharmacists should verify DINs on Health Canada’s database to match product information and formulary listings.
| Drug | Typical Indication | Pros | Cons | Example DIN |
|---|---|---|---|---|
| Domperidone (Motilium) | Antiemetic, motility | Less CNS penetration | Cardiac safety concerns; restricted access | Verify DIN on Health Canada |
| Ondansetron (Zofran) | Chemo/post-op nausea | Well tolerated for oncology use | Higher cost; QT prolongation risk | Verify DIN on Health Canada |
| Granisetron (Kytril) | Oncology antiemetic | Long-acting for chemotherapy | Specialist use; cost | Verify DIN on Health Canada |
Pros And Cons List
Metoclopramide — pros: effective prokinetic, low cost and widely available in generic tablet form.
Metoclopramide — cons: central side effects, strict duration limits and monitoring needs.
Ondansetron — pros: good short-term efficacy in chemo/post-op nausea; cons: cost and cardiac monitoring considerations.
Domperidone — pros: less central nervous system penetration; cons: cardiac safety signals and variable provincial access.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent studies between 2022 and 2025 have concentrated on risk stratification for tardive dyskinesia and strategies to limit cumulative exposure, especially in elderly populations.
Observational Canadian analyses reiterate restricting metoclopramide to the shortest effective duration and highlight increased monitoring in long-term users.
Randomized trials and systematic reviews comparing metoclopramide with 5‑HT3 antagonists show similar short-term antiemetic efficacy in selected settings but different safety profiles that influence choice.
Practice-changing findings include reinforced recommendations for limiting chronic use and increasing pharmacist-led surveillance for movement disorders in seniors.
Common Patient Questions In Canada
Can I get metoclopramide without a prescription?
No — metoclopramide requires a valid prescription in Canada and pharmacists will verify prescriptions before dispensing.
Is it safe in pregnancy?
Use only if benefits outweigh risks; discuss with an obstetric provider and consult provincial prenatal drug programs for coverage and guidance.
How quickly does it work?
Oral tablets often act within 30–60 minutes; IV or IM administration in a clinical setting works faster.
What if I’m elderly or on many medicines?
Pharmacist review is recommended to assess risk of movement disorders and interactions, particularly with antipsychotics or other dopamine antagonists.
Can I buy from the US or online?
Cross-border purchasing is common but carries risks: products may lack a Canadian DIN, prescription validity and import limits should be checked.
Contact a local pharmacy or prescriber for tailored advice and for assistance with provincial coverage or prior-authority procedures.
Regulatory Status
Health Canada Approval Process
Products marketed in Canada must hold a Drug Identification Number (DIN) issued by Health Canada after review of quality, safety and efficacy data.
Product monographs and labelling detail approved indications, dosing, contraindications and post-market safety information that healthcare professionals and patients should consult.
DIN Number Relevance
Pharmacists must check the DIN on packaging to verify that the product matches the prescribing information and provincial formulary listings used for reimbursement decisions.
Reporting adverse events to Health Canada’s post-market surveillance (MedEffect) supports ongoing safety signal detection and can prompt formulary reassessments.
Visual Recommendations
Infographic Ideas For Canadian Context
Create a quick facts card listing INN, typical doses (10 mg tablets; 5 mg/5 mL oral solution), Rx requirement and a DIN placeholder for the product page.
Design a “When To Use” flowchart to help users decide between short-term acute treatment and referral for chronic symptoms.
Include a safety alert strip highlighting high-risk groups such as the elderly, people with renal impairment, pregnant or breastfeeding patients and those on antipsychotics.
Provide bilingual labels (English/French) or alt-text for Quebec users and ensure accessible layout for printed pharmacist counselling cards.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
Always present a valid prescription for metoclopramide when purchasing in Canada.
In-store pharmacists at Shoppers, Rexall and London Drugs can counsel on interactions and side effects; online chains require electronic prescription upload and offer home delivery across many provinces.
Compare in-store retail price, online discounts and provincial dispensing fees and confirm whether provincial drug plans cover the indication before paying out-of-pocket.
In our online pharmacy, maxeran is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Proper Storage With Canadian Climate Considerations
Tablets should be stored below 25°C in original packaging and kept away from moisture and direct light.
Canadian summers and parked vehicles can expose medications to excessive heat; avoid leaving packs in hot cars.
Oral solution should follow label storage instructions, typically below 25°C, and injections are usually refrigerated (2–8°C) for clinic stocks.
Discard expired medication and keep all medicines out of reach of children.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Prescribers and pharmacists should confirm the indication and baseline risk factors such as a history of movement disorders, renal function and concomitant CNS drugs before starting metoclopramide.
Set a clear treatment duration, usually a short course, and arrange follow-up to reassess need and check for adverse effects.
Use the lowest effective dose and document the rationale for paediatric or longer-term prescriptions; elderly patients should receive a written monitoring plan for extrapyramidal signs.
Pharmacists should verify DINs, counsel on interactions — especially with antipsychotics and serotonergic agents — and report adverse events to MedEffect Canada.
Encourage patients to stop the medicine and seek care if involuntary movements or severe central nervous system symptoms occur.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5–7 days |
| Montreal | Quebec | 5–7 days |
| Vancouver | British Columbia | 5–7 days |
| Calgary | Alberta | 5–7 days |
| Edmonton | Alberta | 5–7 days |
| Ottawa | Ontario | 5–7 days |
| Winnipeg | Manitoba | 5–7 days |
| Quebec City | Quebec | 5–7 days |
| Halifax | Nova Scotia | 5–7 days |
| Victoria | British Columbia | 5–7 days |
| Kitchener | Ontario | 5–9 days |
| London | Ontario | 5–9 days |
| Saskatoon | Saskatchewan | 5–9 days |
| Regina | Saskatchewan | 5–9 days |
Final Notes For Patients And Pharmacists
Metoclopramide (Maxeran search term commonly used) is an effective short-term option for many causes of acute nausea but requires a prescription and careful monitoring for movement-related side effects.
Pharmacists should prioritise checking DINs, confirming indication and counselling on expected onset, storage and adverse effects before dispensing.
Patients should carry a clear plan that specifies treatment duration and when to stop and seek medical attention for involuntary movements.
For chronic gastroparesis or repeated need beyond a few weeks, referral to a specialist is recommended to reassess therapy and explore alternatives such as ondansetron or domperidone where appropriate and available.
